DHODH-IN-15 is primarily utilized in the field of medicinal chemistry and drug development. It serves as a potent inhibitor of the dihydroorotate dehydrogenase (DHODH) enzyme, which plays a critical role in the de novo pyrimidine biosynthesis pathway. By targeting this enzyme, DHODH-IN-15 is studied for its potential therapeutic applications in treating diseases that rely on rapid cell proliferation, such as cancer and autoimmune disorders. Additionally, it is being explored for its antiviral properties, particularly against RNA viruses, where inhibiting pyrimidine synthesis can disrupt viral replication. Research is also ongoing to evaluate its efficacy in modulating immune responses, making it a promising candidate for immunotherapy-based treatments.